Senior Director, Oncology Pharmacology

Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments.

This individual will be responsible for leading scientific team members assigned to oncology assets ranging from discovery through regulatory approval. This individual will both manage the oncology pharmacology team and serve as a lead on one or more programs themselves.

Primary responsibilities of the oncology pharmacology team include:

• Establishing efficacy in relevant disease models
• Demonstrating differentiation relative to relevant comparators
• Determining PK/PD/efficacy relationships
• Characterizing mechanisms of action
• Identifying predictive disease models, indications, and biomarkers
• Driving preclinical discovery
• Supporting research and development of Jazz products and drug candidates overall
• Designing and executing studies that address clinically relevant priorities

Operational tasks include:

• Designing and executing experiments that are outsourced or performed by in-house bench researchers or academic collaborators
• Reviewing and contributing to clinical protocols
• Reviewing and authoring technical reports
• Co-authoring sections of regulatory documents ranging from IND to NDA/BLA submissions
• Communicating relevant research at internal and external forums

The oncology pharmacology team is cross-functional, including participation in matrix teams assigned to specific products that include but are not limited to Clinical Development, Bioanalytical, Toxicology, Clinical Pharmacology, Biomarkers, Regulatory Affairs, and Project Management.

Essential Functions:

• Design and execute experiments to elucidate efficacy, tolerability, mechanism of action, and biomarkers associated with complex combinations of multiple therapeutic modalities (small molecules, biologics, ADCs, bi-specifics, cell therapies, and other emerging platforms)
• Critically evaluate biochemical and cellular assays
• Communicate effectively across Jazz functional teams in highly matrixed, cross-functional environments
• Demonstrate strong interpersonal, negotiation, and influence skills
• Independently develop experimental strategies, analyse data, and present results to non‐clinical and governance-level teams
• Collaborate with CROs to outsource studies, develop protocols, manage timelines and budgets, and partner with academic labs for Jazz sponsored research
• Serve as a project team leader and/or as lead pharmacology representative across various oncology programs
• Mentor junior scientists and provide scientific leadership and professional growth opportunities

Required Knowledge, Skills, and Abilities:

• Industry experience evaluating therapeutic potential of drug candidates from hit to lead optimization through IND enabling studies, with deep expertise in oncology drug development
• Broad background in preclinical oncology with strong familiarity with emerging therapeutic modalities, competitive landscapes, and strategic assessment of diverse drug mechanisms
• Extensive experience in Immuno Oncology (I/O), including I/O relevant in vivo and in vitro models, immune cell biology, and integration of immunological endpoints into pharmacology programs
• Demonstrated experience working across multiple drug modalities, including small molecules, biologics, ADCs, bi-specifics, T cell engagers, cell and gene therapies, and RNA based therapeutics
• Strong foundational understanding of the interdependencies between Nonclinical Pharmacology, Toxicology, DMPK, and Clinical Pharmacology
• Deep understanding of cancer signaling pathways and their therapeutic exploitation
• Proven experience leading multiple complex pharmacology programs at diverse CROs, including GLP and non-GLP environments
• Expertise designing and executing studies evaluating efficacy, tolerability, mechanism of action, and biomarker strategies for small molecule and biologic agents
• Ability to integrate preclinical and clinical datasets, innovate, and apply novel methodologies to advance therapeutic programs
• Proficiency with analytical tools (e.g., Graph Pad Prism) and biomarker data analysis
• Direct people management experience, including mentorship, performance development, and leadership of scientific teams
• Strong leadership qualities, self-motivation, and demonstrated success networking across internal teams, academia, industry, and regulatory agencies
• Excellent ability to assess program needs, oversee CRO activities, develop/review protocols, monitor execution, interpret results, and prepare high quality reports for regulatory submissions
• Experience authoring nonclinical components of IND, NDA/BLA/MAA submissions, briefing packages, DSURs, IBs, and fast track designation documents
• Strong project management skills with the ability to manage multiple complex programs simultaneously
• Demonstrated success leading in fast-paced, highly matrixed environments, aligning diverse stakeholders and driving decision making
• Strong analytical and creative problem-solving skills
• Embody and model Jazz core values

Required/Preferred Education and Licenses:

• Ph.D. in biology, biochemistry, immunology, pharmacology, or a related discipline, with experience leading early oncology programs and developing nonclinical models for characterising therapeutic efficacy and pharmacodynamics, including substantial oncology and immuno-oncology experience